NEWS & EVENTS

Latest news and upcoming events

Minoryx and Neuraxpharm announce a strategic alliance to provide a new therapy for rare CNS disease patients in Europe
10 Nov 2022

Minoryx and Neuraxpharm announce a strategic alliance to provide a new therapy for rare CNS disease patients in Europe

Upcoming events
  • Jefferies London Healthcare Conference
    14 - 17 November 2022,
    London

    download
  • Ship2B Impact Forum
    30 November 2022,
    Barcelona

    download
  • BIO-EUROPE 2022
    24 - 26 October 2022,
    Leipzig

    download
Raúl Martín-Ruiz joins Ysios Capital Partners as Investment Manager<

Raúl Martín-Ruiz joins Ysios Capital Partners as Investment Manager

Main responsibilities of Martín-Ruiz will be to analyze and evaluate the feasibility of the target companies of the fund from a scientific and business point of view.

Paula Olazábal joins Ysios Capital Partners as investment manager<

Paula Olazábal joins Ysios Capital Partners as investment manager

Her appointment comes along with the new stage of the venture capital firm specialized in biotech, which is preparing the first closing of Ysios BioFund I.

Ysios Capital Partners names Marc Casellas as Chief Financial Officer<

Ysios Capital Partners names Marc Casellas as Chief Financial Officer

Ysios has created this position to manage the increased activity expected as the initial capital subscription of its first fund, Ysios BioFund I, draws to a close

Ysios Capital Partners announces the imminent first closing of the largest Spanish venture capital fund in the biotech sector<

Ysios Capital Partners announces the imminent first closing of the largest Spanish venture capital fund in the biotech sector

The company anticipates a first closing of around EUR 60 million in brief.

Ysios co-leads €27,2million Series B financing of stem cell company Cellerix

Barcelona, September 20, 2007. ‐ Cellerix, a biopharmaceutical company leader in the clinical development and production of innovative medicines based on adult stem cells, has closed an oversubscribed Series B financing round for €27.2M.

Ysios co-leads €27,2million Series B financing of stem cell company Cellerix<

Ysios co-leads €27,2million Series B financing of stem cell company Cellerix

The round was led by two of the most experienced life science investors in Europe, LSP (Netherlands) and Ventech (France).

Ysios Capital Partners Starts Registration as an Independent Biotech Venture Capital Firm in Spain<

Ysios Capital Partners Starts Registration as an Independent Biotech Venture Capital Firm in Spain

Ysios Capital Partners will be raising €65 million for their first fund, Ysios BioFund I.

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.